Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-05-03
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V I. In Accordance With Section 31 Paragraph 1 Sgb V About Blood Sugar Test Strips, For The Period 01/01/26 - 31/12/27 (plus V. Option 1 Blood Glucose Test St 2026-05-03
Canada Pr19224 - 47419-269614 - Chemical Detection Systems Itq - List Of Qualified Respondents 2026-05-04
Finland Healthcare Services In The Area (dps) 2026-05-04
United Kingdom Dynamic Purchasing System For The Provision Of Domiciliary Care Services In Powys 2026-05-04
Ireland Hse 17753 Dps Qualification For Non Invasive Cardiology Equipment 2026-05-07
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brinzolamide + Brimonidine Atr 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ciprofloxacin Oht + Atr 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Para. 8 Sgb V With The Active Ingredient Bosutinib 2026-05-10
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pomalidomide 2026-05-10
Whats app